• stephanromeijn
• July 12, 2024
• • Updates to Health AI Register
• • cina-ad
  • cina-ich
  • advance chest ct
  • avicenna.ai
  • cina-pe

Avicenna.AI has obtained MDR Class IIb certification for all of their AI products in Europe, which were previously on market under MDD Class I. This includes their CINA-ASPECTS and CINA-AD , CINA-ICH, CINA-iPE, CINA-LVO, CINA-PE. Currently 38% of the AI solutions listed on Health AI register are MDR compliant.

Milvue has received FDA clearance for its SmartChest application.

Deepc adds the ChestLink and ChestEye Quality algorithms of Oxipit to its marketplace.

South Korean AI developer JLK has received FDA clearance for its JPC-01K application for prostate cancer detection.

Contextflow has entered a partnership with Neologica's LogiPACS for the integration of the ADVANCE Chest CT application.